Physician profile
Daniel William Brown
NPI 1225473754
$7,490.71
in general payments reported to CMS, 2019-2025
14 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $57.39 · 2021: $1,200 · 2022: $1,253 · 2023: $4,540 · 2024: $316 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,133 · Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,132.56 |
| Food and Beverage | $848.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,355.91 | 2023 | Expedium |
| Summit Surgical Corp. | $2,400.00 | 2021-2022 | |
| Depuy Synthes Sales INC. | $429.09 | 2020-2024 | Expedium Verse, Expedium, Altalyne |
| Acumed LLC | $71.50 | 2024-2025 | Acumed, Acumed, Osteomed |
| Axogen | $41.08 | 2025 | |
| Medtronic, INC. | $40.25 | 2022 | |
| Kyowa Kirin, INC. | $29.69 | 2025 | |
| Orthofix Medical, INC. | $26.12 | 2025 | Physio-Stim |
| Heron Therapeutics, INC. | $22.03 | 2024 | Zynrelef |
| Amgen INC. | $21.10 | 2024 | Krystexxa |
| Abbott Laboratories | $15.98 | 2023 | Proclaim |
| Zimmer Biomet Holdings, INC. | $13.25 | 2020 | |
| Si-Bone, INC. | $12.51 | 2022 | |
| Bioventus LLC | $12.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.